FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ralph Bernacki

Research Profile

Anatomy

Chemicals & Drugs

Living Beings

Concepts & Ideas

Procedures

Drug Screening Assays, Antitumor

Disorders

Physiology

Co-author Network

Publications

TOP 3
Liang Sun; Jean M Veith; Paula Pera; Ralph J Bernacki; Iwao Ojima
Design and synthesis of de novo cytotoxic alkaloids by mimicking the bioactive conformation of paclitaxel.
Liang Sun; Xudong Geng; Raphaël Geney; Yuan Li; Carlos Simmerling; Zhong Li; Joseph W Lauher; Shujun Xia; Susan B. Horwitz; Jean M Veith; Paula Pera; Ralph J Bernacki; Iwao Ojima
Design, synthesis, and biological evaluation of novel C14-C3'BzN-linked macrocyclic taxoids.
Iwao Ojima; Jin Chen; Liang Sun; Christopher P Borella; Tao Wang; Michael L Miller; Songnian Lin; Xudong Geng; Larisa Kuznetsova; Chuanxing Qu; David Gallager; Xianrui Zhao; Ilaria Zanardi; Shujun Xia; Susan B. Horwitz; Jon Mallen-St Clair; Jennifer Lynn Guerriero; Dafna Bar-Sagi; Jean M Veith; Paula Pera; Ralph J Bernacki
Design, synthesis, and biological evaluation of new-generation taxoids.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ralph Bernacki (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Liang Sun; Jean M Veith; Paula Pera; Ralph J Bernacki; Iwao Ojima
Design and synthesis of de novo cytotoxic alkaloids by mimicking the bioactive conformation of paclitaxel.
Bioorganic & medicinal chemistry 2010;18(19):7101-12.
2008: Liang Sun; Xudong Geng; Raphaël Geney; Yuan Li; Carlos Simmerling; Zhong Li; Joseph W Lauher; Shujun Xia; Susan B. Horwitz; Jean M Veith; Paula Pera; Ralph J Bernacki; Iwao Ojima
Design, synthesis, and biological evaluation of novel C14-C3'BzN-linked macrocyclic taxoids.
The Journal of organic chemistry 2008;73(24):9584-93.
2008: Iwao Ojima; Jin Chen; Liang Sun; Christopher P Borella; Tao Wang; Michael L Miller; Songnian Lin; Xudong Geng; Larisa Kuznetsova; Chuanxing Qu; David Gallager; Xianrui Zhao; Ilaria Zanardi; Shujun Xia; Susan B. Horwitz; Jon Mallen-St Clair; Jennifer Lynn Guerriero; Dafna Bar-Sagi; Jean M Veith; Paula Pera; Ralph J Bernacki
Design, synthesis, and biological evaluation of new-generation taxoids.
Journal of medicinal chemistry 2008;51(11):3203-21.
2008: Ralph J Bernacki
Metronomic chemotherapy and tumor immunomodulation.
Cancer biology & therapy 2008;7(4):602.
2007: Yseult Brun; Carly G Dennis; William R Greco; Ralph J Bernacki; Paula Pera; Jennifer J Bushey; Richard Youn; Donald B White; Brahm H Segal
Modeling the combination of amphotericin B, micafungin, and nikkomycin Z against Aspergillus fumigatus in vitro using a novel response surface paradigm.
Antimicrobial agents and chemotherapy 2007;51(5):1804-12.
2007: Tracy A Brooks; Kieran L O'Loughlin; Hans Minderman; Brian N Bundy; Laurie A Ford; Michael R Vredenburg; Ralph J Bernacki; Waldemar Priebe; Maria R Baer
The 4'-O-benzylated doxorubicin analog WP744 overcomes resistance mediated by P-glycoprotein, multidrug resistance protein and breast cancer resistance protein in cell lines and acute myeloid leukemia cells.
Investigational new drugs 2007;25(2):115-22.
2006: Larissa Kuznetsova; Jin Chen; Liang Sun; Xinyuan Wu; Antonella Pepe; Jean Veith; Paula Pera; Ralph J Bernacki; Iwao Ojima
Syntheses and evaluation of novel fatty acid-second-generation taxoid conjugates as promising anticancer agents.
Bioorganic & medicinal chemistry letters 2006;16(4):974-7.
2006: Carly G Dennis; William R Greco; Yseult Brun; Richard Youn; Harry K Slocum; Ralph J Bernacki; Russell Lewis; Nathan Wiederhold; Steven M Holland; Ruta Petraitiene; THOMAS WALSH; Brahm H Segal
Effect of amphotericin B and micafungin combination on survival, histopathology, and fungal burden in experimental aspergillosis in the p47phox-/- mouse model of chronic granulomatous disease.
Antimicrobial agents and chemotherapy 2006;50(2):422-7.
2005: Michael Bouvet; Joseph Spernyak; Matthew H Katz; richard mazurchuk; Shinako Takimoto; Ralph J Bernacki; Youcef M Rustum; Abdool R Moossa; Robert M Hoffman
High correlation of whole-body red fluorescent protein imaging and magnetic resonance imaging on an orthotopic model of pancreatic cancer.
Cancer research 2005;65(21):9829-33.
2005: Iwao Ojima; Christopher P Borella; Xinyuan Wu; Pierre-Yves Bounaud; Cecilia Fumero Oderda; Matthew Sturm; Michael L Miller; Subrata Chakravarty; Jin Chen; Qing Huang; Paula Pera; Tracy A Brooks; Maria R Baer; Ralph J Bernacki
Design, synthesis and structure-activity relationships of novel taxane-based multidrug resistance reversal agents.
Journal of medicinal chemistry 2005;48(6):2218-28.
2005: Raphaël Geney; Liang Sun; Paula Pera; Ralph J Bernacki; Shujun Xia; Susan B. Horwitz; Carlos Simmerling; Iwao Ojima
Use of the tubulin bound paclitaxel conformation for structure-based rational drug design.
Chemistry & biology 2005;12(3):339-48.
2005: Canio J Marasco; Paula Pera; Arthur J Spiess; Ralph J Bernacki; Janice R Sufrin
Improved synthesis of beta-D-6-methylpurine riboside and antitumor effects of the beta-D- and alpha-D-anomers.
Molecules (Basel, Switzerland) 2005;10(8):1015-20.
2004: Xudong Geng; Raphaël Geney; Paula Pera; Ralph J Bernacki; Iwao Ojima
Design and synthesis of de novo cytotoxic alkaloids through mimicking taxoid skeleton.
Bioorganic & medicinal chemistry letters 2004;14(13):3491-4.
2004: Moustafa E El-Araby; Ralph J Bernacki; Gergely M Makara; Paula Pera; Wayne K Anderson
Synthesis, molecular modeling, and evaluation of nonphenolic indole analogs of mycophenolic acid.
Bioorganic & medicinal chemistry 2004;12(11):2867-79.
2004: Hans Minderman; Tracy A Brooks; Kieran L O'Loughlin; Iwao Ojima; Ralph J Bernacki; Maria R Baer
Broad-spectrum modulation of ATP-binding cassette transport proteins by the taxane derivatives ortataxel (IDN-5109, BAY 59-8862) and tRA96023.
Cancer chemotherapy and pharmacology 2004;53(5):363-9.
2004: Xiang Ling; Ralph J Bernacki; Michael G Brattain; Fengzhi Li
Induction of survivin expression by taxol (paclitaxel) is an early event, which is independent of taxol-mediated G2/M arrest.
The Journal of biological chemistry 2004;279(15):15196-203.
2004: Tracy A Brooks; Daniel R Kennedy; Donald J Gruol; Iwao Ojima; Maria R Baer; Ralph J Bernacki
Structure-activity analysis of taxane-based broad-spectrum multidrug resistance modulators.
Anticancer research 2004;24(2A):409-15.
2004: Giovanni Appendino; Piergiorgio Bettoni; Alain Noncovich; Olov Sterner; Gabriele Fontana; Ezio Bombardelli; Paula Pera; Ralph J Bernacki
Structure-activity relationships of ring C-secotaxoids. 1. Acylative modifications.
Journal of natural products 2004;67(2):184-8.
2004: Nithya Ramnath; J Hamm; Gary Schwartz; S Holden; S G Eckhardt; Michael R Vredenburg; Ralph J Bernacki; C Lathia; Peter Kanter; Patrick J Creaven
A phase I and pharmacokinetic study of BAY59: a novel taxane.
Oncology 2004;67(2):123-9.
2003: Arturo Battaglia; Ralph J Bernacki; Carlo Bertucci; Ezio Bombardelli; Samanta Cimitan; Ferlini Cristiano; Gabriele Fontana; Andrea Guerrini; Antonella Riva
Synthesis and biological evaluation of 2'-methyl taxoids derived from baccatin III and 14beta-OH-baccatin III 1,14-carbonate.
Journal of medicinal chemistry 2003;46(23):4822-5.
2003: Tracy A Brooks; Hans Minderman; Kieran L O'Loughlin; Paula Pera; Iwao Ojima; Maria R Baer; Ralph J Bernacki; Tracy Brooks
Taxane-based reversal agents modulate drug resistance mediated by P-glycoprotein, multidrug resistance protein, and breast cancer resistance protein.
Molecular cancer therapeutics 2003;2(11):1195-205.
2003: Ming Wu; richard mazurchuk; Neeta D Chaudhary; Joseph Spernyak; Jean Veith; Paula Pera; William R Greco; Robert M Hoffman; Tomowo Kobayashi; Ralph J Bernacki
High-resolution magnetic resonance imaging of the efficacy of the cytosine analogue 1-[2-C-cyano-2-deoxy-beta-D-arabino-pentofuranosyl]-N(4)-palmitoyl cytosine (CS-682) in a liver-metastasis athymic nude mouse model.
Cancer research 2003;63(10):2477-82.
2003: Charles J Dimitroff; Ralph J Bernacki; Robert Sackstein
Glycosylation-dependent inhibition of cutaneous lymphocyte-associated antigen expression: implications in modulating lymphocyte migration to skin.
Blood 2003;101(2):602-10.
2002: Canio J Marasco; Debora L Kramer; John Miller; Carl W Porter; Cyrus J Bacchi; Donna Rattendi; Louis S Kucera; Nathan Iyer; Ralph J Bernacki; Paula Pera; Janice R Sufrin
Synthesis and evaluation of analogues of 5'-([(Z)-4-amino-2-butenyl]methylamino)-5'-deoxyadenosine as inhibitors of tumor cell growth, trypanosomal growth, and HIV-1 infectivity.
Journal of medicinal chemistry 2002;45(23):5112-22.
2002: Iwao Ojima; Xudong Geng; Songnian Lin; Paula Pera; Ralph J Bernacki
Design, synthesis and biological activity of novel C2-C3' N-Linked macrocyclic taxoids.
Bioorganic & medicinal chemistry letters 2002;12(3):349-52.
2002: Olga V Leontieva; Maria N Preobrazhenskaya; Ralph J Bernacki
Partial circumvention of P-glycoprotein-mediated multidrug resistance by doxorubicin-14-O-hemiadipate.
Investigational new drugs 2002;20(1):35-48.
2001: Kelly Chibale; Iwao Ojima; H Haupt; Xudong Geng; Paula Pera; Ralph J Bernacki
Modulation of human mammary cell sensitivity to paclitaxel by new quinoline sulfonamides.
Bioorganic & medicinal chemistry letters 2001;11(18):2457-60.
2001: Michael R Vredenburg; Iwao Ojima; Jean Veith; Paula Pera; Kristin Kee; F Cabral; A Sharma; Peter Kanter; William R Greco; Ralph J Bernacki
Effects of orally active taxanes on P-glycoprotein modulation and colon and breast carcinoma drug resistance.
Journal of the National Cancer Institute 2001;93(16):1234-45.
2001: Donald J Gruol; J Bernd; A E Phippard; I Ojima; Ralph J Bernacki
The use of a novel taxane-based P-glycoprotein inhibitor to identify mutations that alter the interaction of the protein with paclitaxel.
Molecular pharmacology 2001;60(1):104-13.
2000: Iwao Ojima; S Lin; JC Slater; T Wang; Paula Pera; Ralph J Bernacki; C Ferlini; Ferlini Cristiano
Syntheses and biological activity of C-3'-difluoromethyl-taxoids.
Bioorganic & medicinal chemistry 2000;8(7):1619-28.
2000: Ralph J Bernacki; Paula Pera; P Gambacorta; Y Brun; William R Greco
In vitro antitumor activity of 9-nitro-camptothecin as a single agent and in combination with other antitumor drugs.
Annals of the New York Academy of Sciences 2000;922():293-7.
1999: Iwao Ojima; T Wang; Michael L Miller; Songnian Lin; Christopher P Borella; Xudong Geng; Paula Pera; Ralph J Bernacki
Synthesis and structure-activity relationships of new second-generation taxoids.
Bioorganic & medicinal chemistry letters 1999;9(24):3423-8.
1999: Charles J Dimitroff; Paula Pera; F Dall'Olio; Khushi L Matta; EV Chandrasekaran; Joseph T Y Lau; Ralph J Bernacki
Cell surface n-acetylneuraminic acid alpha2,3-galactoside-dependent intercellular adhesion of human colon cancer cells.
Biochemical and biophysical research communications 1999;256(3):631-6.
1999: Charles J Dimitroff; Wayne D Klohs; A Sharma; Paula Pera; D Driscoll; Jean Veith; Randall W Steinkampf; M Schroeder; Sylvester R Klutchko; Adam Sumlin; B Henderson; T J Dougherty; Ralph J Bernacki
Anti-angiogenic activity of selected receptor tyrosine kinase inhibitors, PD166285 and PD173074: implications for combination treatment with photodynamic therapy.
Investigational new drugs 1999;17(2):121-35.
1998: Iwao Ojima; Pierre-Yves Bounaud; C Takeuchi; Paula Pera; Ralph J Bernacki
New taxanes as highly efficient reversal agents for multidrug resistance in cancer cells.
Bioorganic & medicinal chemistry letters 1998;8(2):189-94.
1998: Charles J Dimitroff; A Sharma; Ralph J Bernacki
Cancer metastasis: a search for therapeutic inhibition.
Cancer investigation 1998;16(4):279-90.
1998: Z Mi; Debora L Kramer; JT Miller; Raymond J Bergeron; Ralph J Bernacki; Carl W Porter
Human prostatic carcinoma cell lines display altered regulation of polyamine transport in response to polyamine analogs and inhibitors.
The Prostate 1998;34(1):51-60.
1997: Debora L Kramer; M Fogel-Petrovic; Paula Diegelman; J M Cooley; Ralph J Bernacki; James S McManis; Raymond J Bergeron; Carl W Porter
Effects of novel spermine analogues on cell cycle progression and apoptosis in MALME-3M human melanoma cells.
Cancer research 1997;57(24):5521-7.
1997: A Sharma; D Glaves; Carl W Porter; D Raghavan; Ralph J Bernacki
Antitumor efficacy of N1,N11-diethylnorspermine on a human bladder tumor xenograft in nude athymic mice.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(8):1239-44.
1997: A Sharma; E Mayhew; Lois E Bolcsak; C Cavanaugh; Paul A Harmon; AS Janoff; Ralph J Bernacki
Activity of paclitaxel liposome formulations against human ovarian tumor xenografts.
International journal of cancer. Journal international du cancer 1997;71(1):103-7.
1997: Iwao Ojima; Scott D Kuduk; Paula Pera; Jean Veith; Ralph J Bernacki
Synthesis and structure-activity relationships of nonaromatic taxoids: effects of alkyl and alkenyl ester groups on cytotoxicity.
Journal of medicinal chemistry 1997;40(3):279-85.
1997: Iwao Ojima; JC Slater; Scott D Kuduk; C S Takeuchi; R H Gimi; C M Sun; Y H Park; Paula Pera; Jean Veith; Ralph J Bernacki
Syntheses and structure-activity relationships of taxoids derived from 14 beta-hydroxy-10-deacetylbaccatin III.
Journal of medicinal chemistry 1997;40(3):267-78.
1997: A Sharma; Ralph J Bernacki
Ovarian cancer patients with high CA-125 but no symptoms--should antiangiogenic treatments be considered?
Oncology research 1997;9(2):53-4.
1996: Iwao Ojima; J C Slater; E Michaud; Scott D Kuduk; Pierre-Yves Bounaud; P Vrignaud; MC Bissery; Jean Veith; Paula Pera; Ralph J Bernacki
Syntheses and structure-activity relationships of the second-generation antitumor taxoids: exceptional activity against drug-resistant cancer cells.
Journal of medicinal chemistry 1996;39(20):3889-96.
1996: B Woynarowska; Charles J Dimitroff; M Sharma; Khushi L Matta; Ralph J Bernacki
Inhibition of human HT-29 colon carcinoma cell adhesion by a 4-fluoro-glucosamine analogue.
Glycoconjugate journal 1996;13(4):663-74.
1995: A Sharma; Robert M Straubinger; Iwao Ojima; Ralph J Bernacki
Antitumor efficacy of taxane liposomes on a human ovarian tumor xenograft in nude athymic mice.
Journal of pharmaceutical sciences 1995;84(12):1400-4.
1995: N J Angelino; Ralph J Bernacki; M Sharma; O Dodson-Simmons; W Korytnyk
Versatile intermediates in the selective modification of the amino function of 2-amino-2-deoxy-D-mannopyranose and the 3-position of 2-acetamido-2-deoxy-D-mannose: potential membrane modifiers in neoplastic control.
Carbohydrate research 1995;276(1):99-115.
1995: Ralph J Bernacki; E J Oberman; K E Seweryniak; A Atwood; Raymond J Bergeron; Carl W Porter
Preclinical antitumor efficacy of the polyamine analogue N1, N11-diethylnorspermine administered by multiple injection or continuous infusion.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(8):847-57.
1994: B Woynarowska; D M Skrincosky; A Haag; M Sharma; Khushi L Matta; Ralph J Bernacki
Inhibition of lectin-mediated ovarian tumor cell adhesion by sugar analogs.
The Journal of biological chemistry 1994;269(36):22797-803.
1994: EV Chandrasekaran; John Rhodes; RK Jain; Ralph J Bernacki; Khushi L Matta
A biosynthetic control on structures serving as ligands for selectins: the precursor structures, 3-sialyl/sulfo Gal beta 1, 3/4GlcNAc beta-0-R, which are high affinity substrates for alpha 1, 3/4-L-fucosyltransferases, exhibit the phenomenon of substrate inhibition.
Biochemical and biophysical research communications 1994;201(1):78-89.
1994: Iwao Ojima; Y H Park; C M Sun; I Fenoglio; G Appendino; Paula Pera; Ralph J Bernacki
Structure-activity relationships of new taxoids derived from 14 beta-hydroxy-10-deacetylbaccatin III.
Journal of medicinal chemistry 1994;37(10):1408-10.
1993: D M Skrincosky; HJ Allen; Ralph J Bernacki
Galaptin-mediated adhesion of human ovarian carcinoma A121 cells and detection of cellular galaptin-binding glycoproteins.
Cancer research 1993;53(11):2667-75.
1993: Francesca M Tumminello; Ralph J Bernacki; Nicola Gebbia; Gaetano Leto
Pepstatins: aspartic proteinase inhibitors having potential therapeutic applications.
Medicinal research reviews 1993;13(2):199-208.
1993: M Sharma; Ralph J Bernacki; M J Hillman; W Korytnyk
Fluorinated carbohydrates as potential plasma membrane modifiers. Synthesis of 3-deoxy-3-fluoro derivatives of 2-acetamido-2-deoxy-D-hexopyranoses.
Carbohydrate research 1993;240():85-93.
1993: Carl W Porter; Ralph J Bernacki; J Miller; Raymond J Bergeron
Antitumor activity of N1,N11-bis(ethyl)norspermine against human melanoma xenografts and possible biochemical correlates of drug action.
Cancer research 1993;53(3):581-6.
1992: Ralph J Bernacki; Raymond J Bergeron; Carl W Porter
Antitumor activity of N,N'-bis(ethyl)spermine homologues against human MALME-3 melanoma xenografts.
Cancer research 1992;52(9):2424-30.
1992: B Woynarowska; H Wikiel; M Sharma; N Carpenter; G W Fleet; Ralph J Bernacki
Inhibition of human ovarian carcinoma cell- and hexosaminidase- mediated degradation of extracellular matrix by sugar analogs.
Anticancer research 1992;12(1):161-6.
1991: Janice R Sufrin; Arthur J Spiess; Debora L Kramer; P R Libby; J T Miller; Ralph J Bernacki; Y H Lee; R T Borchardt; Carl W Porter
Targeting 5'-deoxy-5'-(methylthio)adenosine phosphorylase by 5'-haloalkyl analogues of 5'-deoxy-5'-(methylthio)adenosine.
Journal of medicinal chemistry 1991;34(8):2600-6.
1991: L Weiss; Ralph J Bernacki; G Elkin; M Hillman
Effects of doxorubicin on the sensitivity of L1210 leukemia cells to deformation-associated trauma.
Cell biophysics 1991;18(1):57-67.
1990: M Sharma; Ralph J Bernacki; B Paul; W Korytnyk
Fluorinated carbohydrates as potential plasma membrane modifiers. Synthesis of 4- and 6-fluoro derivatives of 2-acetamido-2-deoxy-D-hexopyranoses.
Carbohydrate research 1990;198(2):205-21.
1990: HJ Allen; D Sucato; B Woynarowska; S Gottstine; A Sharma; Ralph J Bernacki
Role of galaptin in ovarian carcinoma adhesion to extracellular matrix in vitro.
Journal of cellular biochemistry 1990;43(1):43-57.
1990: C E Morreal; Ralph J Bernacki; M Hillman; A Atwood; D Cartonia
Antitumor properties of tetrahydrobenz[a]anthraquinone derivatives.
Journal of medicinal chemistry 1990;33(2):490-2.
1990: Gaetano Leto; Francesca M Tumminello; Nicola Gebbia; B Woynarowska; Ralph J Bernacki
Antimetastatic activity of adriamycin in combinations with proteinase inhibitors in mice.
Anticancer research 1990;10(1):265-9.
1989: B Woynarowska; H Wikiel; Ralph J Bernacki
Human ovarian carcinoma beta-N-acetylglucosaminidase isoenzymes and their role in extracellular matrix degradation.
Cancer research 1989;49(20):5598-604.
1989: Francesca M Tumminello; Gaetano Leto; Nicola Gebbia; Luciano Rausa; Ralph J Bernacki
Evaluation of antitumor and antimetastatic activity of pepstatin A in some experimental tumor models.
Journal of chemotherapy (Florence, Italy) 1989;1(4 Suppl):1135-8.
1989: M Bobek; S H An; D Skrincosky; E De Clercq; Ralph J Bernacki
2'-Fluorinated isonucleosides. 1. Synthesis and biological activity of some methyl 2'-deoxy-2'-fluoro-2'-pyrimidinyl-D-arabinopyranosides.
Journal of medicinal chemistry 1989;32(4):799-807.
1989: K Crickard; M J Niedbala; U Crickard; M Yoonessi; A A Sandberg; K Okuyama; Ralph J Bernacki; S K Satchidanand
Characterization of human ovarian and endometrial carcinoma cell lines established on extracellular matrix.
Gynecologic oncology 1989;32(2):163-73.
1988: H H Lee; P G Hodgson; Ralph J Bernacki; W Korytnyk; M Sharma
Analogs of cell surface carbohydrates. Synthesis of D-galactose derivatives having an ethynyl, vinyl or epoxy residue at C-5.
Carbohydrate research 1988;176(1):59-72.
1987: M J Niedbala; R Madiyalakan; K Matta; K Crickard; M Sharma; Ralph J Bernacki
Role of glycosidases in human ovarian carcinoma cell mediated degradation of subendothelial extracellular matrix.
Cancer research 1987;47(17):4634-41.
1987: M Bobek; S H An; D Skrincosky; E De Clerq; Ralph J Bernacki
2'-fluorinated pyrimidine isonucleosides. Novel nucleoside analogs demonstrate therapeutic activity in mice with tumors.
Nucleic acids symposium series 1987;(18):5-7.
1986: M A Bulbul; K Pavelic; Harry K Slocum; O S Frankfurt; Y M Rustum; R P Huben; Ralph J Bernacki
Growth of human urologic tumors on extracellular matrix.
The Journal of urology 1986;136(2):512-6.
1986: K Pavelic; M A Bulbul; Harry K Slocum; Z P Pavelic; Y M Rustum; M J Niedbala; Ralph J Bernacki
Growth of human urological tumors on extracellular matrix as a model for the in vitro cultivation of primary human tumor explants.
Cancer research 1986;46(7):3653-62.
1985: Ralph J Bernacki; G L Wilson; B T Mossman; N Angelino; P M Kanter; W Korytnyk
Therapeutic and diabetogenic potential of two newly synthesized nitrosoureido sugars.
Cancer research 1985;45(2):695-702.
1985: Ralph J Bernacki; M J Niedbala; W Korytnyk
Glycosidases in cancer and invasion.
Cancer metastasis reviews 1985;4(1):81-101.
1983: M J Morin; Ralph J Bernacki
Biochemical effects and therapeutic potential of tunicamycin in murine L1210 leukemia.
Cancer research 1983;43(4):1669-74.
1983: M J Morin; C W Porter; C R Petrie; W Korytnyk; Ralph J Bernacki
Effects of a membrane sugar analogue, 6-deoxy-6-fluoro-D-galactose, on the L1210 leukemic cell ectosialyltransferase system.
Biochemical pharmacology 1983;32(3):553-61.
1983: M J Morin; C W Porter; P McKernan; Ralph J Bernacki
The biochemical and ultrastructural effects of tunicamycin and D-glucosamine in L1210 leukemic cells.
Journal of cellular physiology 1983;114(2):162-72.
1982: W Korytnyk; Janice R Sufrin; Ralph J Bernacki
Alternative syntheses of 2,6-dideoxy-L-lyxo-hexose (2-deoxy-L-fucose) and its biochemical properties.
Carbohydrate research 1982;103(1):170-5.
1980: B Paul; Ralph J Bernacki; W Korytnyk
Synthesis and biological activity of some 1-N-substituted 2-acetamido-2-deoxy-beta-D-glycopyranosylamine derivatives and related analogs.
Carbohydrate research 1980;80(1):99-115.
1980: Janice R Sufrin; Ralph J Bernacki; M J Morin; W Korytnyk
Halogenated L-fucose and D-galactose analogues: synthesis and metabolic effects.
Journal of medicinal chemistry 1980;23(2):143-9.